North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,314 Jan 1 – Oct 26, 2026
- Disclosed funding
- $254B 1919 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| XH XCaliber HealthCompany profile Automates healthcare workflows across EHR, scheduling, and referrals using agentic AI for provider groups Automates healthcare workflows across EHR, scheduling, and referrals using agentic AI for provider groups | $6.5M | Seed | Healthtech | United States | Investors | |
| R RadixArkCompany profile Builds open-source AI inference and training infrastructure, commercializing the SGLang engine Builds open-source AI inference and training infrastructure, commercializing the SGLang engine | $100M | Seed | AI | United States | Investors | |
 4D PathCompany profile Digital biomarkers designed to predict cancer treatment response from routine biopsy images. Digital biomarkers designed to predict cancer treatment response from routine biopsy images. | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors Undisclosed | |
| M MoritzCompany profile Combines AI with lawyers to deliver commercial legal services with same-day turnaround Combines AI with lawyers to deliver commercial legal services with same-day turnaround | $9M | Pre-SeedPre-seed | Enterprise software | United States | Investors | |
| E ElevenLabsCompany profile Develops voice AI models and audio synthesis tools for enterprise and consumer applications Develops voice AI models and audio synthesis tools for enterprise and consumer applications | Undisclosed | Undisclosed | AI | United States | Investors | |
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| V VillageCompany profile Builds AI-powered platform connecting families, providers, and payers for coordinated specialty pediatric care Builds AI-powered platform connecting families, providers, and payers for coordinated specialty pediatric care | $9.5M | Seed | Healthtech | United States | Investors | |
| ME Moment EnergyCompany profile Manufactures certified, commercial-scale battery energy storage systems using repurposed EV batteries Manufactures certified, commercial-scale battery energy storage systems using repurposed EV batteries | >$40M | Series B | Climate tech | United States | Investors | |
| N Provides AI-powered execution of enterprise workflows with human validation | $21.5M | Seed | AI | United States | Investors | |
| LB Latus Bio, Inc.Company profile Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2 Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2 | $97M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
99rounds20led - 3General Catalyst
Provision Labs, Tractian, Different
71rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.